News
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...
Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...
Mounjaro has become popular as a weight loss drug but it also seems to be linked to hair loss in some cases in a worrying new ...
Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
Ozempic time!” one viewer commented after seeing Russell Crowe, who turned heads over the weekend with a noticeably slimmer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results